During a week-long joint operation between U.S. Customs and Border Protection and U.S. Food and Drug Administration, CBP officers inspected hundreds of boxes containing possible counterfeit and unapproved medications at the Port of Cincinnati. A wide variety of unapproved FDA drugs were discovered during inspections including counterfeit injectables and pills.

The operation was a success with a total of 54,843 counterfeit products seized. Had all these items been legitimate, the combined value of all the products would have been over $3.53 million.

During the operation, CBP officers intercepted shipments containing counterfeit Ozempic, Semaglutide, Retatrutide, and Tirzepatide, injections in demand for positive results in weight loss. Ozempic is FDA-approved for the treatment of type 2 d

See Full Page